1
项与 GeniusVacMel4 相关的临床试验Dose-escalation Study to Assess the Safety and Tolerability of Sub-cutaneous Injections of a Peptide-loaded Plasmacytoid Dendritic Cell Line (GeniusVac-Mel4) in Patients With Melanoma
The primary objective of this study is to evaluate the safety and tolerability of multiple sub-cutaneous injections of GeniusVac-Mel4, a dendritic cell-based cancer vaccine, in patients with melanoma. The secondary objectives are to determine immune response and clinical efficacy of such injections in patients with melanoma.
100 项与 GeniusVacMel4 相关的临床结果
100 项与 GeniusVacMel4 相关的转化医学
100 项与 GeniusVacMel4 相关的专利(医药)
100 项与 GeniusVacMel4 相关的药物交易